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Synopsis
2',3'-Di-0-acyladenosine-5'-phosphate and 2',3'-di-0-acyl-uridine-5'-phosphate (acyl = palmitoyl and
stearoyl) were synthesized from the corresponding nucleosides. These lipids were converted readily into
well-defined liposomes (diameter, 200-1000A) upon sonication in water. The liposomal membranes having
the palmitoyl and stearoyl groups showed a main phase transition in a temperature range of 42-45 and 51-57
°C, respectively.
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Introduction
Various amphiphiles have been known to produce bilayer assemblies such as the liposomes. l The vesicles
accommodating various substances in the hydrophobic membrane and/or the aqueous interior have been
studied in pharmaceutical, cosmetic and other fields.2,3 Lipid components of those vesicles include: natural
lipids, chemically modified natural lipids, and synthetic products.4,s We wish to describe here the synthesis
of a new type of phospholipid (1-4 of Scheme 1) starting from nucleosides.
Results and Discussion
Although various lipoid compounds bearing nucleic acid-related moieties have been reported, many of them
were the 1,2-0-diacyl (or dialkyl)glycerols, which were attached to nucleic acid-bases, nucleosides and
nucleotides driectly, or derivative(s) of the nonnatural double chain-lipophilic compounds connected with
the nucleic acid-parts.6- 11 By contrast, 1-4 are the 5'-nucleotide derivatives having long chain-acyl groups at
the 2'-0 and 3'-0 positions.
The nucleotide-lipids could be prepared easily by a series of well-known reactions as displayed in
Scheme 1. The following procedure is typical. Palmitoyl chloride (3.6 g, 13 mmol) was added to an ice-
cooled chloroform solution (30 ml) of 5'-0-trityluridine (3.0g, 6.2 mmol) and anhydrous pyridine (5 ml).
After stirring magnetically overnight at room temperature, the reaction mixture was washed with water,
dried over sodium sulfate and concentrated to give the residue, which was stirred subsequently with 5%
acetic acid-HBr (25 ml) to precipitate trityl alcohol immediately. The reaction mixture was filtered and
fractionated between chloroform and water. The organic layer was washed with water, dried and
concentrated to afford 2',3'-di-0-palmitoyluridine, which was recrystallized from chloroform; 1.7 g
(38%);m.p. 109-112 °C; RrO.51 (chloroform-methanol, 15:1 v/v). Next, the di-O-acylurdine (0.20 g, 0,28
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mmol) in THF was allowed to react with phosphoryl chloride (2 ml) at room temperature for a day, cooled
and stirred with 0.1 M potassium chloride (10 ml) for a few hours. The resulting reaction mixture was
fractionated between water (pH 2 by hydrochloric acid) and chloroform. The organic layer was
concentrated to give the
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Scheme 1.
residue which was applied to the gel column (Sephadex LH-20) equilibrated \vith a mixture of chloroform-
methanol (2: 1 v/v). Elution with the same solvent provided 2',3'-di-O-palmitoyluridine-5'-phosphate (1) as a
colorless solid, 76 mg (34%). Table 1 displays the overall yields, physical constants, etc. of the nucleotide-
lipids prepared.
The compounds (1-4) were found to give readily rise to organic assemblies upon sonication in water.
Namely, a suspension of the lipids in pure water (1-2 mg/ml) was treated by means of a prove-type sonicator
at 120 W per 1 cm2 of a cross sectional area of a titan tip and at 55°C (for the lipids having palmitoyl
chains) or 65°C (for the lipids having stearoyl chains) for 5 min x 6 times. The resulting transparent
aqueous suspensions were centrifuged at 2000 g for 10 min, and the resulting supernatant were subjected to
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Table 1. Yields a, band physical constants c,d of various nucleot~de-lipids(1-4), and
Tm of the liposomal membranes.
yield, 18%; m.p. 157-160 DC; RrO.15; Amax258 nm (e12600 in THF); <3 0.87 (two t, 6H,
2CH3), 6.25 (d, IH, J=6.5 Hz, 1'-H), 8.19 (s, IH, 2-H) and 8.58 (s, IH, 8-H); FABMS m/e
1 (reI. intensity) 822 (M-l)- (80); Tm' 45 DC, ~H, 6.4 kcal/mole.
yield, 20%; m.p. 163-166 DC; Rr 0.20; Amax = 256 nm (E 11900 in a mixture of methanol and
THF, 4:1 v/v); <3 0.87 (complex m, 6H, 2CH3), 6.20 (d, IH, J=6.5 Hz, 1'-H), 8.08 (s, IH, 2-
2 H) and 8.54 (s, IH, 8-H); FABMS m/e (reI. intensity) 880 (M-l)- (7); Tm, 57 °C,~H, 8.1
kcal/mole.
yield, 21%; m.p. 57-62°C; RrO.06; Amax = 257 nm (e8700 in a mixture of methanol and THF,
4:1 v/v); <3 0.85 (m, 6H, 2CH3), 5.49 (d, IH, 1'-H, J=63 Hz), 6.00 (m, IH, 5-H) and 7.78 (m,
3 IH, 6-H); FABMS m/e (reI. intensity) 799 (M-lr (50); Tm, 42.6 °C,aH, 6.3 kcal/moI.
yield, 24%.; m.p. 93-97 DC; RrO.l0 ; Amax = 258 nm (e7600 in methanol-THF = 4:1 v/v); <3
0.88 (m, 6H, 2CH3), 5.50 (d, IH, 1'-H, J=33 Hz), 5.90 (m, IH, 5-H) and 7.63 (m, IH, 6-H);
4 FABMS m/e (reI. intensity) 855 (M-l)- (45); Tm, 51.3 DC, ~H, 6.8 kcal/moI.
a All of the nucleotide-lipids in the table had the elemental analysis (C, H and N) agreed with the
assigned structure within ±0.3 %. b The overall synthesis-yield on the basis of the used amounts of
adenosine or uridine. C The solvent systems used in TLC was chloroform-methanol-concentrated
ammonia = 65:30:3 v/v/v. d The 400 MHz IH-NMR spectra were measured by means ofa Jeol
GX-400 spectrometer using a dilute solution in CDCl3 and CD30D (2:1 v/v) and tetramethylsilane
as an internal standard. FABMS spectra were taken by a Jeol HX-100 spectrometer in a negative
ion mode. Samples in glycerol as a matrix was subjected to a beam of xenon atom produced at 8 kV
and 2 rnA. The main transition temperature (Tm) was obtained from heating curves recorded with a
Rigaku DSC-8230 differential scanning calorimeter (lipid concentration = 8-9 mg/ml) by the
procedure similar to that mentioned previously.I3
transmission electron microscopy to show small unilamellar or multilamellar vesicles. Typical micrographs
are displayed in Figure 1. A light scattering study of the aqueous suspension suggested 200-1000 A as a
size distribution of the vesicles. Sonication of the lipid in an aqueous solution of 5(6)-carboxyfluoresceine
followed by gel column chromatography (GPC) using Sephadex G-50 using water as a solvent 13 furnished
an aqueous suspension of the liposomes containing the dye in the initial yellow band, which was well
separated from the latter band of untrapped dye. The liposomes were formed quantitatively; viz., an GPC-
eluent containing the liposomes was freeze dried to give 80-950/0 weight of the used amounts of the
nucleotide-lipids. While the liposomal membranes of 1-4 were similar in a main phase transition
temperature (Tm) to the membranes of the corresponding phosphatidylcholines, the formers were smaller in
the ~H than the latter (Table 1); c.f., the liposomal membranes of 1,2-dipalmitoyl-sn-glycero-3-
phosphocholine and the distearoyl isomer had a main transition temperature of 41.4 and 54.9 °c and ~H of
8.7 and 10.6 kcal/mole, respectively. The low ~H values of the membranes of 1-4 has not been explained
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well, but it might be caused by a restricted rotation between 2'-C and 3'C atoms to disrupt the regular
packing of the neighboring chains. The liposome morphology of 1-4 was preserved at least for several
hours at ambient temperature. A 1:1-5 molar mixture of 1-4 and an ordinary lipid such as egg lecithin
afforded well defined and more stable liposomes. The use of the nucleotide-lipids has been under study.
Figure 1. Transmission electron micrographs; negatively stained by phosphotungstic
acid/NaOH (pH 7): a and b from 1 and 3, respectively. A bar is IoooA.
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